The landscape of dementia diagnosis has progressed radically with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology several years just before signs and symptoms arise. Although these technological innovations characterize exceptional development in knowing neurodegenerative illnesses, they may https://scottq753scm3.nizarblog.com/profile